{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:36:43Z","timestamp":1790419003449,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.hoc.2007.06.005","type":"journal-article","created":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T07:27:28Z","timestamp":1185866848000},"page":"685-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Drug-Induced Thrombocytopenia"],"prefix":"10.1016","volume":"21","author":[{"given":"Gian Paolo","family":"Visentin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2007.06.005_bib1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1592\/phco.20.4.292.34883","article-title":"Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient","volume":"20","author":"Wazny","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.hoc.2007.06.005_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-2006-924952","article-title":"[Differential diagnosis of platelet disorders]","volume":"131","author":"Rothe","year":"2006","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.hoc.2007.06.005_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0025-6196(12)60247-X","article-title":"Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences","volume":"59","author":"Payne","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hoc.2007.06.005_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/00365519709055287","article-title":"Screening for EDTA-dependent deviations in platelet counts and abnormalities in platelet distribution histograms in pseudothrombocytopenia","volume":"57","author":"Bartels","year":"1997","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.hoc.2007.06.005_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0735-1097(00)00688-4","article-title":"Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy","volume":"36","author":"Sane","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2007.06.005_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1468-0734.2001.00041.x","article-title":"Drug-induced and drug-dependent immune thrombocytopenias","volume":"5","author":"Greinacher","year":"2001","journal-title":"Rev Clin Exp Hematol"},{"key":"10.1016\/j.hoc.2007.06.005_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/106002809502900901","article-title":"Thrombocytopenia in intensive care patients: a comprehensive analysis of risk factors in 314 patients","volume":"29","author":"Bonfiglio","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.hoc.2007.06.005_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1592\/phco.22.11.803.33634","article-title":"Risk markers for thrombocytopenia in critically ill patients: a prospective analysis","volume":"22","author":"Shalansky","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.hoc.2007.06.005_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0272-5231(03)00100-X","article-title":"Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients","volume":"24","author":"Drews","year":"2003","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.hoc.2007.06.005_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/039139880502800506","article-title":"Plasma therapies in thrombotic syndromes","volume":"28","author":"Nguyen","year":"2005","journal-title":"Int J\u00a0Artif Organs"},{"key":"10.1016\/j.hoc.2007.06.005_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002280050272","article-title":"Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy","volume":"52","author":"Pedersen-Bjergaard","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.hoc.2007.06.005_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00002018-200326100-00003","article-title":"Drug-induced myelosuppression: diagnosis and management","volume":"26","author":"Carey","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.hoc.2007.06.005_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00320276","article-title":"Cyclophosphamide-induced immune thrombocytopenia in a patient with ovarian carcinoma successfully treated with intravenous gamma globulin","volume":"46","author":"Mueller-Eckhardt","year":"1983","journal-title":"Blut"},{"key":"10.1016\/j.hoc.2007.06.005_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/1097-0142(19930201)71:3<851::AID-CNCR2820710331>3.0.CO;2-M","article-title":"Immune-mediated thrombocytopenia secondary to suramin","volume":"71","author":"Seidman","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2007.06.005_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1008232514137","article-title":"Irinotecan-induced immune thrombocytopenia","volume":"9","author":"Bozec","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2007.06.005_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mpo.10416","article-title":"Selective thrombocytopenia in children with Wilms tumor: an immune-mediated effect of dactinomycin?","volume":"41","author":"Shannon","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.hoc.2007.06.005_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ajh.20516","article-title":"Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin","volume":"81","author":"Curtis","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2007.06.005_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0025-7125(16)30147-X","article-title":"Thrombocytopenia. Issues in diagnosis and therapy","volume":"78","author":"Rutherford","year":"1994","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.hoc.2007.06.005_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3949\/ccjm.69.3.259","article-title":"What is the best way to determine if thrombocytopenia in a patient on multiple medications is drug-induced?","volume":"69","author":"Majhail","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.hoc.2007.06.005_bib20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jama.1971.03180160076026","article-title":"Hydrochlorothiazide-dependent thrombocytopenia due to IgM antibody","volume":"215","author":"Eisner","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2007.06.005_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tox.2004.12.031","article-title":"Drug-induced immune cytopenias","volume":"209","author":"Aster","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.hoc.2007.06.005_bib22","first-page":"2","article-title":"Drug-induced immune thrombocytopenia: an overview of pathogenesis","volume":"36","author":"Aster","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2007.06.005_bib23","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood.V77.10.2190.2190","article-title":"Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb\/IIIa complexes for the quinine\/quinidine-dependent antibodies","volume":"77","author":"Chong","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1182\/blood.V84.1.176.176","article-title":"Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb\/IIIa complex","volume":"84","author":"Curtis","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib25","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1182\/blood.V92.7.2359","article-title":"An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies","volume":"92","author":"Gentilini","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib26","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1182\/blood.V95.6.1988","article-title":"Rifampicin-dependent antibodies bind a similar or identical epitope to glycoprotein IX-specific quinine-dependent antibodies","volume":"95","author":"Burgess","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2165\/00002018-200427150-00007","article-title":"Drug-induced immune thrombocytopenia","volume":"27","author":"van den Bemt","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.hoc.2007.06.005_bib28","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2007.06.005_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00002018-200730020-00007","article-title":"Drug-induced thrombocytopenia: an updated systematic review, 2006","volume":"30","author":"Li","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.hoc.2007.06.005_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ajh.10148","article-title":"Spontaneous reports of thrombocytopenia in association with quinine: clinical attributes and timing related to regulatory action","volume":"70","author":"Brinker","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2007.06.005_bib31","series-title":"Heparin-induced thrombocytopenia","first-page":"107","article-title":"Frequency of heparin-induced thrombocytopenia","author":"Lee","year":"2003"},{"key":"10.1016\/j.hoc.2007.06.005_bib32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1172\/JCI111691","article-title":"Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia","volume":"75","author":"Christie","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2007.06.005_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/206362a0","article-title":"Penicillin allergy: the formation of the penicilloyl determinant","volume":"206","author":"Batchelor","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2007.06.005_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1523-1747.1998.00122.x","article-title":"Molecular features of penicillin allergy","volume":"110","author":"Weltzien","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.hoc.2007.06.005_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0300-483X(95)03253-C","article-title":"T cell immune responses to haptens. Structural models for allergic and autoimmune reactions","volume":"107","author":"Weltzien","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.hoc.2007.06.005_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0887-7963(93)70145-5","article-title":"Immune cytopenia associated with antibiotics","volume":"7","author":"Garratty","year":"1993","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.hoc.2007.06.005_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2141.1983.tb01233.x","article-title":"Demonstration of an immune-mediated mechanism of penicillin-induced neutropenia and thrombocytopenia","volume":"55","author":"Murphy","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2007.06.005_bib38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1537-2995.1984.24585017827.x","article-title":"Red cell and platelet-bound IgG penicillin antibodies in a patient with thrombocytopenia","volume":"24","author":"Salamon","year":"1984","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2007.06.005_bib39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4049\/jimmunol.126.2.398","article-title":"Further studies of the human platelet receptor for quinine- and quinine-dependent antibodies","volume":"126","author":"Kunicki","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.hoc.2007.06.005_bib40","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood.V66.6.1292.1292","article-title":"Molecular characterization of quinine\/quinidine drug-dependent antibody platelet interaction using monoclonal antibodies","volume":"66","author":"Berndt","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib41","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood.V67.5.1377.1377","article-title":"Quinidine purpura: evidence that glycoprotein V is a target platelet antigen","volume":"67","author":"Stricker","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2141.1987.tb02329.x","article-title":"Quinine- and quinidine platelet antibodies can react with GPIIb\/IIIa","volume":"67","author":"Christie","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2007.06.005_bib43","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood.V96.4.1409","article-title":"Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia","volume":"96","author":"Kroll","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib44","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1182\/blood.V97.12.3846","article-title":"Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen","volume":"97","author":"Bougie","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib45","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood.V92.7.2366","article-title":"Quinine-dependent antibodies bind a restricted set of epitopes on the glycoprotein Ib-IX complex: characterization of the epitopes","volume":"92","author":"Burgess","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib46","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1182\/blood.V77.12.2668.2668","article-title":"Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa","volume":"77","author":"Visentin","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib47","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2006-01-009803","article-title":"Patients with quinine-induced immune thrombocytopenia have both \u201cdrug-dependent\u201d and \u201cdrug-specific\u201d antibodies","volume":"108","author":"Bougie","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib48","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2002-07-2336","article-title":"A site involving the \u201chybrid\u201d and PSI homology domains of GPIIIa (beta 3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia","volume":"101","author":"Peterson","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib49","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood-2002-07-2175","article-title":"Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies","volume":"102","author":"Asvadi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib50","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1378\/chest.127.2_suppl.53S","article-title":"Immune thrombocytopenia caused by glycoprotein IIb\/IIIa inhibitors","volume":"127","author":"Aster","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.hoc.2007.06.005_bib51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.amjcard.2005.08.066","article-title":"Frequency and management of thrombocytopenia with the glycoprotein IIb\/IIIa receptor antagonists","volume":"97","author":"Huxtable","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hoc.2007.06.005_bib52","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1055\/s-0037-1613330","article-title":"Acute thrombocytopenia in patients treated with the oral glycoprotein IIb\/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology","volume":"88","author":"Brassard","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.06.005_bib53","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1172\/JCI119307","article-title":"Platelet GPIIb\/IIIa antagonists: the first anti-integrin receptor therapeutics","volume":"99","author":"Coller","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2007.06.005_bib54","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1538-7836.2006.01829.x","article-title":"Thrombocytopenia associated with the use of GPIIb\/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb\/IIIa inhibitors","volume":"4","author":"Aster","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.06.005_bib55","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1182\/blood.V100.6.2071","article-title":"Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb\/IIIa","volume":"100","author":"Bougie","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib56","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/09537100500140141","article-title":"Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events","volume":"16","author":"Dunkley","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.hoc.2007.06.005_bib57","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1538-7836.2004.00744.x","article-title":"Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug","volume":"2","author":"Curtis","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.06.005_bib58","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood.V99.6.2054","article-title":"Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets","volume":"99","author":"Curtis","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib59","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood.V66.2.306.306","article-title":"Drug-dependent and non-drug-dependent antiplatelet antibody in drug-induced immunologic thrombocytopenic purpura","volume":"66","author":"Lerner","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib60","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0037-1963(00)90101-X","article-title":"Can drugs cause autoimmune thrombocytopenic purpura?","volume":"37","author":"Aster","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2007.06.005_bib61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2141.1986.tb07528.x","article-title":"Thrombocytopenia associated with gold therapy: a drug-induced autoimmune disease?","volume":"63","author":"dem Borne","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2007.06.005_bib62","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1084\/jem.181.6.1945","article-title":"How can cryptic epitopes trigger autoimmunity?","volume":"181","author":"Lanzavecchia","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.hoc.2007.06.005_bib63","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1146\/annurev.iy.11.040193.003501","article-title":"Dominance and crypticity of T cell antigenic determinants","volume":"11","author":"Sercarz","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.hoc.2007.06.005_bib64","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0952-7915(95)80056-5","article-title":"Metal ion induced autoimmunity","volume":"7","author":"Griem","year":"1995","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.hoc.2007.06.005_bib65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.1830260202","article-title":"Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides","volume":"26","author":"Griem","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.hoc.2007.06.005_bib66","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0161-5890(98)00106-0","article-title":"Drug-induced inhibition of insulin recognition by T-cells: the antirheumatic drug aurothiomalate inhibits MHC binding of insulin peptide","volume":"35","author":"Takahashi","year":"1998","journal-title":"Mol Immunol"},{"key":"10.1016\/j.hoc.2007.06.005_bib67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1172\/JCI115569","article-title":"Gold-specific T cells in rheumatoid arthritis patients treated with gold","volume":"89","author":"Romagnoli","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2007.06.005_bib68","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1084\/jem.181.6.1957","article-title":"Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants","volume":"181","author":"Simitsek","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.hoc.2007.06.005_bib69","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1084\/jem.181.6.2253","article-title":"HIVgp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing","volume":"181","author":"Salemi","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.hoc.2007.06.005_bib70","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-68-1-176","article-title":"Coombs'-test positivity induced by drugs. Mechanisms of immunologic reactions and red cell destruction","volume":"68","author":"Croft","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2007.06.005_bib71","doi-asserted-by":"crossref","first-page":"506","DOI":"10.7326\/0003-4819-60-3-506","article-title":"A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in auto-immunity. Combined clinical staff conference at the national institutes of health","volume":"60","author":"Shulman","year":"1964","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2007.06.005_bib72","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1172\/JCI112901","article-title":"Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent","volume":"79","author":"Smith","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2007.06.005_bib73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0038-1656329","article-title":"Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia","volume":"68","author":"Amiral","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.06.005_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2007.06.005_bib75","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.06.005_bib76","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1182\/blood.V83.11.3232.3232","article-title":"Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4","volume":"83","author":"Kelton","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib77","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0037-1615865","article-title":"Heparin-induced thrombocytopenia: molecular pathogenesis","volume":"82","author":"Visentin","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.06.005_bib78","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2007.06.005_bib79","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2004-831039","article-title":"An overview of the heparin-induced thrombocytopenia syndrome","volume":"30","author":"Warkentin","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.hoc.2007.06.005_bib80","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1537-2995.1990.30891020326.x","article-title":"Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry","volume":"30","author":"Visentin","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2007.06.005_bib81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0887-7963(93)70147-9","article-title":"Laboratory investigation of drug-induced immune thrombocytopenias","volume":"7","author":"McFarland","year":"1993","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.hoc.2007.06.005_bib82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-3148.1992.tb00153.x","article-title":"The MAIPA assay and its applications in immunohaematology","volume":"2","author":"Kiefel","year":"1992","journal-title":"Transfus Med"},{"key":"10.1016\/j.hoc.2007.06.005_bib83","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1537-2995.1987.27387235635.x","article-title":"Metabolite-specific (IgG) and drug-specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia","volume":"27","author":"Kiefel","year":"1987","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2007.06.005_bib84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0887-7963(90)70249-0","article-title":"Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites","volume":"4","author":"Mueller-Eckhardt","year":"1990","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.hoc.2007.06.005_bib85","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood.V90.1.407.407_407_413","article-title":"Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia","volume":"90","author":"Bougie","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.005_bib86","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1399-0039.1981.tb00667.x","article-title":"Drug-induced antibodies: interaction of the drug with a polymorphic platelet-antigen","volume":"17","author":"Claas","year":"1981","journal-title":"Tissue Antigens"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858807000743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858807000743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:49:56Z","timestamp":1760183396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858807000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0889858807000743"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2007.06.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Induced Thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2007.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}